Prøve GULL - Gratis
India eyes ₹5,000 cr plan to be pharma innovation hub
Mint Mumbai
|February 27, 2025
While Indian companies have dominated in generic drugs, they are laggards in R&D
India is making a push to move beyond its dominance in generic drugs and establish itself as a hub for pharmaceutical innovation.
The government will invite expressions of interest in March for a ₹5,000 crore funding corpus aimed at accelerating research in drug discovery, medical technology (medtech), and stem cell therapy, with bid submissions expected in April.
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme—launched in August 2023 for a five-year period—seeks to boost domestic R&D and reduce India's reliance on imported technology.
"We are planning to float the expression of interest (EOI) very likely early next month to get a sense how companies are coming forward and based on the response, we will invite bids in April," said an official from the department of pharmaceuticals, familiar with the matter.
Denne historien er fra February 27, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
In India's car labs, Chinese models new benchmark
Walk into the vehicle development centre of any major Indian carmaker and you'll find dozens of rival cars stripped to their bones, engineers poring over every exposed circuit, nut and wire. Such 'benchmark-ing' helps companies understand why some models work while others don't, track technology trends, and plan their own vehicle roadmaps.
2 mins
November 17, 2025
Mint Mumbai
Insurance merger plan gets new life
Centre weighs consolidating National, Oriental, United
3 mins
November 17, 2025
Mint Mumbai
India's telecom spectrum: Who actually owns it?
On 13 November, the Supreme Court reserved its order on how spectrum held by Aircel and Reliance Communications (RCom) will be treated under their insolvency proceedings. The decision will bring clarity on whether spectrum can be sold to recover dues. Mint. explores.
2 mins
November 17, 2025
Mint Mumbai
Why are India's rich finally protesting for a better life?
They stood holding English placards, some of which even had commas.
4 mins
November 17, 2025
Mint Mumbai
BJP FACES TWO TESTS: ELECTORAL & FISCAL
The mammoth win in Bihar is done and dusted. Can the Bharatiya Janata Party (BJP) now break into regional bastions in the upcoming state polls in 2026, and can it continue hiking welfare spending to garner votes?
4 mins
November 17, 2025
Mint Mumbai
Resilience spells hope as uncertainty reigns high
As trade-policy turmoil prolongs global uncertainty on an IMF index, we have some bright spots too. India should consider shifting focus from supply-side policies to demand stirrers
2 mins
November 17, 2025
Mint Mumbai
IFC, two others may pick 49% in green H₂ maker Hygenco
The World Bank's International Finance Corp. (IFC), Munich-headquartered Siemens AG, and Singapore's Fullerton Fund Management may acquire at least 49% in Gurugram-based green hydrogen manufacturer Hygenco Green Energies Pvt. Ltd, two people aware of the development said.
4 mins
November 17, 2025
Mint Mumbai
DO YOU OWN PAPER OR GOLD? THE CRITICAL FINE PRINT ON SGBS
Ow Bertie is quite chuffed that he owns Sovereign Gold Bonds (SGBs).
2 mins
November 17, 2025
Mint Mumbai
Financial sector’s report card reveals regulatory gaps
The quinquennial report cards on India’s financial sector have been issued and they present a disturbing picture.
3 mins
November 17, 2025
Mint Mumbai
NEW WAVE OF TECH IPOs LEAVES RETAIL INVESTORS AT RISK
The Indian stock markets are bracing for another wave of what the fashionable set calls 'digital IPOs'.
3 mins
November 17, 2025
Listen
Translate
Change font size